Concepedia

Publication | Open Access

Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy

DOIFull Paper Access

232

Citations

44

References

2017

Year

Kevin Winthrop, Jeffrey R. Curtis, Stephen Lindsey, Yoshiya Tanaka, Kunihiro Yamaoka, Hernán Valdez, Tomohiro Hirose, Chudy I. Nduaka, Lisy Wang, Alan M. Mendelsohn,
Arthritis & Rheumatology

Abstract

Patients receiving treatment with tofacitinib and GCs appear to have a greater risk of developing HZ compared with patients receiving tofacitinib monotherapy without GCs.

References

YearCitations

Page 1